CHANGING EXPRESSION OF GTPASE-ACTIVATING PROTEINS WITH DIFFERENTIATION IN NEUROBLASTOMA

被引:7
作者
BURCHILL, SA
BERRY, PA
LEWIS, IJ
机构
[1] Candlelighters Children's Research Laboratory, Imperial Cancer Research Fund, Cancer Medicine Research Unit and Paediatric Oncology, Leeds
关键词
GTPASE ACTIVATING PROTEINS; NEUROBLASTOMA; DIFFERENTIATION; GROWTH; RETINOIC ACID; RT-PCR;
D O I
10.1016/0022-510X(94)90261-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
p21(ras) is a membrane-associated guanine nucleotide-binding protein with intrinsic GTPase activity. Like other guanine nucleotide-binding proteins p21(ras) is active when GTP bound and inactive when GDP bound. Phosphorylation of p21(ras) is regulated by the GTPase activity of type I GAP(120) and NF1-GRD. In this study we have identified type I GAP(120) and two NF1-GRD mRNAs in three neuroblastoma cell lines, IMR-32, SK-N-SH and SK-N-MC. NF1-GRD mRNA was expressed in all cell lines at a similar level but type I GAP(120) mRNA was more abundant in the IMR-32 cell line. Retinoic acid induced differentiation of all three cell lines, this effect was most marked in the SK-N-SH line. This differentiation was accompanied by an increase in both type I GAP(120) and NF1-GRD mRNAs. Retinoic acid induced differentiation had no effect on the ratio of type I to type II NF1-GRD mRNA. In seven patient tumour samples examined type I GAP(120) and NF1-GRD were coexpressed, type I GAP(120) at a higher level than NF1-GRD in all tumour stages. Type I was the predominant NF1-GRD mRNA. The expression of type I GAP(120) was similar in all tumour stages but the total level of NF1-GRD was higher in stage 2 and 3 tumours than in stage 4 tumours. In summary, these results suggest increased type I GAP(120) and NF1-GRD mRNA are associated with differentiation in neuroblastoma cells.
引用
收藏
页码:126 / 132
页数:7
相关论文
共 26 条
  • [1] DIFFERENTIAL REGULATION OF CELLULAR ACTIVITIES BY GTPASE-ACTIVATING PROTEIN AND NF1
    ALALAWI, N
    XU, GF
    WHITE, R
    CLARK, R
    MCCORMICK, F
    FERAMISCO, JR
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (04) : 2497 - 2503
  • [2] THE NF1 LOCUS ENCODES A PROTEIN FUNCTIONALLY RELATED TO MAMMALIAN GAP AND YEAST IRA PROTEINS
    BALLESTER, R
    MARCHUK, D
    BOGUSKI, M
    SAULINO, A
    LETCHER, R
    WIGLER, M
    COLLINS, F
    [J]. CELL, 1990, 63 (04) : 851 - 859
  • [3] MICROINJECTION OF THE RAS ONCOGENE PROTEIN INTO PC12 CELLS INDUCES MORPHOLOGICAL-DIFFERENTIATION
    BARSAGI, D
    FERAMISCO, JR
    [J]. CELL, 1985, 42 (03) : 841 - 848
  • [4] ABERRANT REGULATION OF RAS PROTEINS IN MALIGNANT-TUMOR CELLS FROM TYPE-1 NEUROFIBROMATOSIS PATIENTS
    BASU, TN
    GUTMANN, DH
    FLETCHER, JA
    GLOVER, TW
    COLLINS, FS
    DOWNWARD, J
    [J]. NATURE, 1992, 356 (6371) : 713 - 715
  • [5] COMPLETE HUMAN NF1 CDNA SEQUENCE - 2 ALTERNATIVELY SPLICED MESSENGER-RNAS AND ABSENCE OF EXPRESSION IN A NEUROBLASTOMA LINE
    BERNARDS, A
    HAASE, VH
    MURTHY, AE
    MENON, A
    HANNIGAN, GE
    GUSELLA, JF
    [J]. DNA AND CELL BIOLOGY, 1992, 11 (10) : 727 - 734
  • [6] BOTTENSTEIN JE, 1981, FUNCTIONALLY DIFFERE, P155
  • [7] INTERNATIONAL CRITERIA FOR DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT IN PATIENTS WITH NEURO-BLASTOMA
    BRODEUR, GM
    SEEGER, RC
    BARRETT, A
    BERTHOLD, F
    CASTLEBERRY, RP
    DANGIO, G
    DEBERNARDI, B
    EVANS, AE
    FAVROT, M
    FREEMAN, AI
    HAASE, G
    HARTMANN, O
    HAYES, FA
    HELSON, L
    KEMSHEAD, J
    LAMPERT, F
    NINANE, J
    OHKAWA, H
    PHILIP, T
    PINKERTON, CR
    PRITCHARD, J
    SAWADA, T
    SIEGEL, S
    SMITH, EI
    TSUCHIDA, Y
    VOUTE, PA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (12) : 1874 - 1881
  • [8] CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
  • [9] ABNORMAL REGULATION OF MAMMALIAN P21(RAS) CONTRIBUTES TO MALIGNANT-TUMOR GROWTH IN VONRECKLINGHAUSEN (TYPE-1) NEUROFIBROMATOSIS
    DECLUE, JE
    PAPAGEORGE, AG
    FLETCHER, JA
    DIEHL, SR
    RATNER, N
    VASS, WC
    LOWY, DR
    [J]. CELL, 1992, 69 (02) : 265 - 273
  • [10] IDENTIFICATION AND CHARACTERIZATION OF THE NEUROFIBROMATOSIS TYPE-1 PROTEIN PRODUCT
    DECLUE, JE
    COHEN, BD
    LOWY, DR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (22) : 9914 - 9918